Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
AI-Discovered IPF Drug: Phase 2a Trial Results

AI-Discovered IPF Drug: Phase 2a Trial Results

June 3, 2025 Health

Harnessing the⁢ power⁣ of artificial intelligence, a groundbreaking⁣ drug for idiopathic pulmonary fibrosis (IPF) has emerged, marking a meaningful stride in the fight against⁢ this debilitating disease. The ⁢Phase ⁣2a trial ⁢results are ​in, offering a critical look at the efficacy ⁤and safety of this AI-discovered treatment. News ⁣Directory 3⁣ delivers the latest news about the trial, it’s innovative approach,‍ and the⁣ potential impact on IPF patients. Discover the key findings‍ from the recent clinical trial,⁣ analyze the data alongside the leading researchers, and examine the drug’s mechanisms of​ action. Plus, understand the implications ⁢for future ‍IPF treatments⁢ and the evolution of AI in drug discovery. Explore the promise of this new solution,and determine what the next steps are in⁣ this promising ⁢field.

Okay, I’ve extracted the reference details from the provided text. Here’s the data, ⁤formatted for better readability:

Reference ⁣59

authors: Acharya, P.S., Zukas, A., Chandan, V., Katzenstein, A-LA, & Puré, E.
Title: Fibroblast​ activation protein: a serine protease expressed⁤ at ‍the remodeling interface in ‍idiopathic pulmonary fibrosis
Journal: ⁢ Hum.Pathol.
DOI: 10.1016/j.humpath.2005.11.020
Volume: 37
Pages: 352-360
Year: ‍ 2006

Reference ⁣60

authors: Hoffman, ​E. T. et ⁢al. Title: ​Regional and disease specific human lung extracellular matrix composition.
Journal: Biomaterials
DOI: 10.1016/j.biomaterials.2022.121960
Volume: 293
Pages: 121960
Year: 2023

Reference⁢ 61

Author: Shum, L.
Title: Chondroadherin binds to type II collagen.
Journal: Arthritis Res. Ther.
DOI: 10.1186/ar-2001-72650
volume: 3
Pages: ‌ 72650
Year: 2001

Reference 62

Authors: Raghu, G. et al.
Title: ⁤ Idiopathic⁢ pulmonary ‌fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline
Journal: Am. ⁤J. Respir. Crit. Care Med.
DOI: 10.1164/rccm.202202-0399ST
Volume: 205
pages: e18–e47
Year: 2022

Reference 63

Authors: Graham, B. L. et al.
Title: Standardization of Spirometry 2019 Update. An Official American‌ Thoracic ⁣Society and European Respiratory‌ Society Technical ⁤Statement
Journal: Am. J. Respir. Crit. Care Med.
DOI: 10.1164/rccm.201908-1590ST
Volume: 200
Pages: ⁣ E70 – E88
Year: 2019

Reference 64

Authors: ⁢ Graham, B. L.et al.
Title: 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung
Journal: eur. Respir.J.
DOI: 10.1183/13993003.00016-2016
Volume: ‍ 49
Pages: 1600016
Year: 2017

I have omitted reference⁣ 65 as the provided text was cut ⁣off.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Biomedicine, Cancer Research, drug development, General, infectious diseases, Metabolic Diseases, Molecular Medicine, Neurosciences, Predictive markers, Respiratory tract diseases

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service